Transitional Care for Pediatrics
(H2H-CYSHCN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two support systems, known as Hospital-to-Home Transitional Care Interventions, to aid children with special health care needs in transitioning from hospital to home. The goal is to determine whether a short-term or long-term support plan more effectively reduces hospital visits and boosts parents' confidence in caring for their child. The study focuses on how these plans work for children with complex needs and aims to reduce health disparities among different racial and ethnic groups. Families who might be suitable have children under 18, have consulted multiple specialists in the past year, and will be returning home after their hospital stay. As an unphased trial, this study offers families the opportunity to contribute to important research that could enhance care transitions for children with special health care needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these Hospital-to-Home Transitional Care Interventions are safe for children and youth with special health care needs?
Research has shown that Hospital-to-Home Transitional Care Interventions (H2H-TCI) are generally safe and well-received by patients. Studies have found that these programs can reduce hospital readmissions, indicating improved patient health without harm. For instance, one study showed that a more intensive program reduced hospital readmissions from 42% to 29%, demonstrating effectiveness without introducing new risks.
Additionally, a review of various programs for children leaving the hospital found they also led to reduced use of health services. This further supports the absence of major safety issues or significant side effects. While individual experiences may vary, the evidence so far supports the safety of H2H-TCI.12345Why are researchers excited about this trial?
Researchers are excited about the hospital-to-home transitional care interventions for pediatric patients because these approaches aim to smooth the transition from hospital to home, potentially reducing readmissions and improving overall health outcomes. Unlike traditional care, which often leaves gaps in communication and support once patients leave the hospital, these interventions offer continuous, personalized care during this critical period. The unique aspect here is the tailored support, which can include follow-up visits, phone check-ins, and coordination with community healthcare providers, ensuring a seamless and supportive transition for young patients and their families.
What evidence suggests that this trial's Hospital-to-Home Transitional Care Interventions could be effective for CYSHCN?
Research has shown that assisting families in transitioning from hospital to home can significantly reduce the likelihood of readmission for children with special health needs. This trial will compare two approaches: the Focused Dose Hospital-to-Home Transitional Care Interventions and the Extended Dose Hospital-to-Home Transitional Care Interventions. One study found that a more intensive support program reduced readmissions from 42% to 29% within three months. Another review highlighted that these programs also enhance care coordination, easing the transition for children with complex medical issues. These programs provide structured support and resources to families, boosting their confidence and decreasing the need for emergency care. The overall goal is to deliver personalized care tailored to each child's specific health needs.13567
Who Is on the Research Team?
David Ming, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for children with special health care needs who have been hospitalized and seen in two or more distinct specialty areas within the last year. It's designed to help these kids transition from hospital to home.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a focused or extended dose of hospital-to-home Transitional Care Interventions (H2H-TCI) post-discharge
Follow-up
Participants are monitored for health service use and caregiver-reported outcomes post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hospital-to-Home Transitional Care Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator